Analyzing ovarian cancer tissue samples of patients treated with cisplatin-based chemotherapy, Mano et al. found that Bcl-2 expression was associated with a poor response, thus identifying the gene as an important prognostic factor [58]. Here, BCL2 is linked to ovarian cancer.